Skip to content
10-K

Annual Report

NEXUS BIOPHARMA INC

0001477932-16-009183

← back to feed
Filed
Mar 28, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 21, 2016 63.8M sh
Shares Diluted FY 2015 · Dec 31, 2015 63.8M sh
Shares Diluted FY 2015 · Dec 31, 2014 63.8M sh
Stockholders Equity FY 2015 · Dec 31, 2015 −$85.42K
Stockholders Equity FY 2015 · Dec 31, 2014 −$43.57K
Stockholders Equity FY 2015 · Dec 31, 2013 −$42.17K
Total Liabilities FY 2015 · Dec 31, 2015 $85.42K
Total Liabilities FY 2015 · Dec 31, 2014 $48.57K
Total Assets FY 2015 · Dec 31, 2015 $0
Total Assets FY 2015 · Dec 31, 2014 $5K
Sga Expense FY 2015 · Dec 31, 2015 $41.85K
Sga Expense FY 2015 · Dec 31, 2014 $1.4K
Net Income FY 2015 · Dec 31, 2015 −$41.85K
Net Income FY 2015 · Dec 31, 2014 −$1.4K